Phase II Trial of R115777 (NSC-702818), an Inhibitor of Farnesyl Protein Transferase, in Patients With Previously Untreated Metastatic Pancreatic Adenocarcinoma.
Phase of Trial: Phase II
Latest Information Update: 02 May 2007
At a glance
- Drugs Tipifarnib (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 02 May 2007 Status changed from in progress to completed.
- 16 Oct 2005 New trial record.